|
Dec 22
|
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
|
|
Dec 22
|
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
|
|
Dec 22
|
Dow Jones Futures Fall As Nike Dives; Apple Leads Six Stocks To Watch With Inflation Data Due
|
|
Dec 21
|
UPDATE 2-US FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
|
|
Dec 21
|
Universal Health (UHS) Up 17% in 3 Months: More Growth Ahead?
|
|
Dec 21
|
Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA
|
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|
|
Dec 21
|
Looking to Invest in the Next Big Craze Like Ozempic? This 1 Emerging Field Could Be It.
|
|
Dec 21
|
Novo Nordisk A/S (NVO) Reported a Strong Third Quarter
|
|
Dec 20
|
Why Novo Nordisk Stock Was Up on a Down Day for the Market
|
|
Dec 20
|
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
|
|
Dec 20
|
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
|
|
Dec 20
|
4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
|
|
Dec 19
|
Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings
|
|
Dec 19
|
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
|
|
Dec 19
|
Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer
|
|
Dec 8
|
Merck's (MRK) Keytruda-Lynparza Combo Fails Lung Cancer Study
|
|
Dec 8
|
Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy?
|
|
Dec 8
|
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
|
|
Dec 7
|
Pharvaris (PHVS) Stock Up 18% on HAE Drug Meeting Study Goal
|